1. The Epithelial-Immune Crosstalk in Pulmonary Fibrosis
   Thomas Planté-Bordeneuve et al, 2021, Frontiers in Immunology CrossRef
2. Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations
   Tihong Shao et al, 2021, Frontiers in Immunology CrossRef
3. Co-trimoxazole to reduce mortality, transplant, or unplanned hospitalisation in people with moderate to very severe idiopathic pulmonary fibrosis: the EME-TIPAC RCT
   Andrew M Wilson et al, 2021, Efficacy and Mechanism Evaluation CrossRef
4. Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
   Anna Valeria Samarelli et al, 2021, International Journal of Molecular Sciences CrossRef
5. The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases
   Jae-Won Lee et al, 2021, Cells CrossRef
6. Impact of Genetic Variation in TLR4 3′UTR on NSCLC Genetic Susceptibility
   Hongjiao Wu et al, 2020, Journal of Oncology CrossRef
7. Lipoteichoic acids from Staphylococcus aureus stimulate proliferation of human non-small-cell lung cancer cells in vitro
   Katja Hattar et al, 2017, Cancer Immunology, Immunotherapy CrossRef
8. Roles of Toll-Like Receptor 3 in Human Tumors
   Xin Zheng et al, 2021, Frontiers in Immunology CrossRef
9. Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis
   Jacob E Michalski et al, 2021, Journal of Inflammation Research CrossRef
10. Research Progress of Prognostic Biomarkers in Idiopathic Pulmonary Fibrosis
    静 任, 2022, Advances in Clinical Medicine CrossRef
11. Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
    Stefania Cuzzubbo et al, 2021, Frontiers in Immunology CrossRef
12. Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance
    Shu Wang et al, 2021, OncoTargets and Therapy CrossRef